At CES 2026, iMogul AI pitches a smarter path into Hollywood

Mogul AI is designed to help screenwriters, actors and producers connect — using artificial intelligence not to create ...

‘Weapons’: Read The Screenplay For Zach Cregger’s Horror Mystery That Turns A Community’s Grief Into A Nightmare

Writer-director Zach Cregger described the writing process for Weapons as "writing on a tightrope," entering the script ...

Accord BioPharma's HERCESSI™ (trastuzumab-strf) Gains Preferred Status on Express Scripts National Commercial Formularies

Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of ...

Accord BioPharma's HERCESSI(TM) (trastuzumab-strf) Gains Preferred Status on Express Scripts National Commercial Formularies

HERCESSI(TM) becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...